ESCRS - PO646 - Implantation Of A Presbyopia Correcting Iol With New Hydrophobic Material: 12 Months Results.

Implantation Of A Presbyopia Correcting Iol With New Hydrophobic Material: 12 Months Results.

Published 2024 - 42nd Congress of the ESCRS

Reference: PO646 | Type: Free paper | DOI: 10.82333/558p-cg71

Authors: Thomas Kohnen* 1 , Eva Hemkeppler 1 , Zubeida Omerovic 1 , Jakob Wend 1 , Klemens Kaiser 1 , Marvin Biller 1 , Petra Davidova 1 , Annika Klinkenbusch 1

1Ophthalmology,Goethe University Hospital,Frankfurt am Main,Germany

Purpose

To evaluate outcomes on visual acuity at different distances, range of vision, patient satisfaction, spectacle independence, visual quality and refractive outcomes in cataract patients implanted with the trifocal Clareon PanOptix®/ Toric IOL.

Setting

Department of Ophthalmology, Goethe-University , Frankfurt, Germany

Methods

Analysis of a prospective, single-site, clinical trial in the Department of Ophthalmology, Goethe University, Frankfurt, Germany including patients after bilateral implantation of the Clareon PanOptix/ Toric IOL. After 3-, 6- and 12-months follow-up, binocular uncorrected and corrected visual acuities at distance (UCDVA, BCDVA), intermediate (UCIVA, DCIVA) and near (UCNVA, DCNVA) was measured. Spectacle independence, defocus curve ranging from -5.0 D to +2.0 D in 0.5D steps, patient satisfaction, visual disturbances, contrast sensitivity and the presence of glistenings were evaluated.

Results

We enrolled 27 patients with an average age of 63.5 ± 7.22 years in the clinical trial. Twelve months postoperative (13 patients until now) monocular UDVA, UIVA in 60cm and 80cm was >0.1logMAR and UNVA in 40cm was >0.2logMAR. Binocular UDVA, UIVA in 60cm and 80cm and UNVA in 40cm was >0.1logMAR. Defocus curve shows two peaks at 0D and 2D. All patients are spectacle independent in all distances. 69% of the included patients reported halos at night. Contrast sensitivity was 1.72 ± 0.48logCS under photopic conditions, 0.98 ± 0.26logCS under mesopic conditions and 0.88 ± 0.14logCS under mesopic with glare conditions. There were no glistenings in all patients 12 months postoperatively.

Conclusions

Visual performance of the PanOptix IOL showed good VA at all distances, high patient satisfaction and spectacle independence,  good contrast sensitivity with no glistenings in 12 months postoperatively.